LANTERN PHARMA INC. (LTRN)
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET
Lantern Pharma to Report Fourth Quarter and Fiscal Year 2025 Operating & Financial Results on March 30th, 2026 at 4:30 p.m. ET
📈 **POSITIVE** • High confidence analysis (85%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business